Analyst Expectations for DexCom's Future
Portfolio Pulse from Benzinga Insights
DexCom (NASDAQ:DXCM) has received mixed analyst ratings in the last quarter, with 3 bullish, 2 somewhat bullish, and 3 indifferent ratings. The average 12-month price target among 8 analysts is $118.12, which is a 15.11% decrease from the previous target of $139.14. The high target is $145.00 and the low target is $98.00. Analysts rate stocks to provide investment guidance, but their opinions are not infallible.
December 04, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
DexCom has seen a mix of analyst ratings and a downward revision in the average price target, suggesting a cautious outlook from analysts.
The reduction in the average price target for DexCom indicates that analysts have become more bearish on the stock's future performance. This could lead to a negative short-term impact on the stock price as investors adjust their expectations. However, the presence of bullish and somewhat bullish ratings also suggests that there is some optimism, which might mitigate the negative impact to some extent.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100